These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 3108684)

  • 1. Haemolytic-uraemic syndrome associated with mitomycin-C treatment.
    Wils J; Grave W; van Breda Vriesman PJ
    Neth J Med; 1987 Feb; 30(1-2):32-5. PubMed ID: 3108684
    [No Abstract]   [Full Text] [Related]  

  • 2. Two patients suffering from interstitial pneumonitis and haemolytic-uraemic syndrome as side effects of mitomycin C therapy.
    van Spreeuwel JP; Hemrika MH; de Maat CE; Nadorp JH
    Neth J Med; 1983; 26(9):287-8. PubMed ID: 6419134
    [No Abstract]   [Full Text] [Related]  

  • 3. Mitomycin C: interstitial pneumonitis and haemolytic-uraemic syndrome.
    Boven E; Pinedo HM
    Neth J Med; 1983; 26(6):153-6. PubMed ID: 6412148
    [No Abstract]   [Full Text] [Related]  

  • 4. Two patients with a fatal haemolytic-uremic syndrome after combination therapy including mitomycin C.
    Boven E; Pinedo HM
    Neth J Med; 1983; 26(9):288. PubMed ID: 6419135
    [No Abstract]   [Full Text] [Related]  

  • 5. Pulmonary angiomatoid vascular changes in mitomycin C-associated hemolytic-uremic syndrome.
    Chang-Poon VY; Hwang WS; Wong A; Berry J; Klassen J; Poon MC
    Arch Pathol Lab Med; 1985 Sep; 109(9):877-8. PubMed ID: 3927871
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Uremic hemolytic syndrome induced by mitomycin C. Presentation of a series of 5 cases and review of the literature].
    Nicolás JM; Villalta J; González-Clemente JM; Antúnez E; Almirall J; Bosch J; Torras A; Urbano-Márquez A
    Rev Clin Esp; 1990 Mar; 186(4):166-70. PubMed ID: 2114657
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Chemotherapy-induced hemolytic uremic syndrome. A complication to mitomycin treatment of breast carcinoma].
    Schjølseth SA; Hagen T; Ottestad L; Jakobsen E
    Tidsskr Nor Laegeforen; 1995 Nov; 115(27):3371-3. PubMed ID: 7491579
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Hemolytic-uremic syndrome caused by mitomycin C].
    de Insausti CL; Gutiérrez LE
    Sangre (Barc); 1988 Aug; 33(4):319-20. PubMed ID: 3142062
    [No Abstract]   [Full Text] [Related]  

  • 9. Hemolytic-uremic syndrome in a patient receiving mitomycin C and 5-fluorouracil.
    Willie GR; Levy SM; Michaels RS; Zirkin RM
    Henry Ford Hosp Med J; 1983; 31(2):104-9. PubMed ID: 6313552
    [No Abstract]   [Full Text] [Related]  

  • 10. Mitomycin C-induced pulmonary and renal toxicities.
    Loprinzi CL
    Wis Med J; 1984 Mar; 83(3):16-7. PubMed ID: 6428065
    [No Abstract]   [Full Text] [Related]  

  • 11. Mitomycin-induced hemolytic uremic syndrome: case presentation and review of literature.
    Rabadi SJ; Khandekar JD; Miller HJ
    Cancer Treat Rep; 1982 May; 66(5):1244-7. PubMed ID: 7083229
    [No Abstract]   [Full Text] [Related]  

  • 12. Hemolytic-uremic syndrome associated with mitomycin therapy.
    Pavy MD; Wiley EL; Abeloff MD
    Cancer Treat Rep; 1982 Mar; 66(3):457-61. PubMed ID: 7060035
    [No Abstract]   [Full Text] [Related]  

  • 13. Haemolytic-uraemic syndrome complicating long-term mitomycin C and 5-fluorouracil therapy for gastric carcinoma.
    Crocker J; Jones EL
    J Clin Pathol; 1983 Jan; 36(1):24-9. PubMed ID: 6401771
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Female with breast cancer, undergoing chemotherapeutic treatment hospitalized because of general deterioration, anemia and renal insufficiency].
    Rev Clin Esp; 1990 Jun; 187(2):82-8. PubMed ID: 2123041
    [No Abstract]   [Full Text] [Related]  

  • 15. [Nephrotoxicity of mitomycin C (apropos of 25 case reports). Results of a multicenter survey organized by the Society of Nephrology].
    Cordonnier D; Vert-Pré FC; Bayle F; Alix JL; Couderc P
    Nephrologie; 1985; 6(1):19-26. PubMed ID: 3923381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of mitomycin-C-associated hemolytic uremic syndrome with plasmapheresis.
    Poch E; Almirall J; Nicolas JM; Torras A; Revert L
    Nephron; 1990; 55(1):89-90. PubMed ID: 2112726
    [No Abstract]   [Full Text] [Related]  

  • 17. Cancer-associated hemolytic uremic syndrome: a possible role of mitomycin in relation to Shiga-like toxins.
    Acheson DW; Donohue-Rolfe A
    J Clin Oncol; 1989 Dec; 7(12):1943. PubMed ID: 2511278
    [No Abstract]   [Full Text] [Related]  

  • 18. Hemolytic-uremic syndrome after cancer chemotherapy without mitomycin C.
    Desablens B; Fievet P; Pruna A; Claisse JF; Westeel PF; Tolani M; Fournier A
    Nephron; 1986; 42(4):343-4. PubMed ID: 3083278
    [No Abstract]   [Full Text] [Related]  

  • 19. [Anatomo-clinical conference. Hôpital de la Pitié-Salpêtrière. Case n. 2-1987. Anemia, thrombopenia and renal insufficiency in a patient treated for cancer of the pancreas].
    Follezou JY; Baumelou A; Audebert A; Beaufils H; Karkouche B
    Ann Med Interne (Paris); 1987; 138(4):308-14. PubMed ID: 3115166
    [No Abstract]   [Full Text] [Related]  

  • 20. Mitomycin-induced hemolytic-uremic syndrome.
    Proia AD; Harden EA; Silberman HR
    Arch Pathol Lab Med; 1984 Dec; 108(12):959-62. PubMed ID: 6210069
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.